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The increased number of outbreaks of H5 and H7 LPAI and HPAI viruses in poultry has major public and animal health
implications. The continuous rapid evolution of these subtypes and the emergence of new variants influence the ability to
undertake effective surveillance. Retroviral pseudotypes bearing influenza haemagglutinin (HA) and neuraminidase (NA) envelope
glycoproteins represent a flexible platform for sensitive, readily standardized influenza serological assays. We describe a multiplex
assay for the study of neutralizing antibodies that are directed against both influenza H5 and H7 HA. This assay permits the
measurement of neutralizing antibody responses against two antigenically distinct HAs in the same serum/plasma sample thus
increasing the amount and quality of serological data that can be acquired from valuable sera. Sera obtained from chickens
vaccinatedwith amonovalentH5N2 vaccine, chickens vaccinatedwith a bivalentH7N1/H5N9 vaccine, or turkeys naturally infected
with an H7N3 virus were evaluated in this assay and the results correlated strongly with data obtained by HI assay. We show
that pseudotypes are highly stable under basic cold-chain storage conditions and following multiple rounds of freeze-thaw. We
propose that this robust assay may have practical utility for in-field serosurveillance and vaccine studies in resource-limited regions
worldwide.
1. Introduction
The increased number of outbreaks of H5 and H7 low patho-
genicity avian influenza (LPAI) and high pathogenicity avian
influenza (HPAI) viruses in poultry has major public and
animal health implications and significant economic impact.
The evaluation of evidence of influenza infection or vacci-
nation efficiency in poultry species is assessed via the mea-
surement of immunological responses against avian influenza
viruses and serological assays representing an important tool
for serosurveillance studies particularly in new outbreak
locations. Although vaccination, combined with improved
biosecurity has successfully prevented significant mortalities
and production loss, on-going evolution of the virus requires
the development of surveillance systems to ensure that vacci-
nation continues to be effective [1].
Influenza A viruses infecting poultry are divided into
two groups (HPAI and LPAI) on the basis of their ability to
cause disease and with different human and animal health
implications. Evidence [2, 3] supports the hypothesis that
HPAI viruses arise as a result of mutations after the virus has
been introduced from wild birds into poultry and thus, it is
believed that LPAI viruses are the progenitors of the highly
pathogenic variants [4]. It has been recognized as important
to control not only HPAI viruses, but also LPAI strains in
domestic poultry [5] despite current knowledge on themech-
anisms of mutation from LPAI to HPAI being insufficient
for predicting which influenza strains will mutate into HPAI
variants [6, 7]. Despite significant efforts being put into the
development of avian vaccines, serological surveillance repre-
sents one of themajor tools for evaluating the immune state of
avian populations especially for the ability of certain subtypes
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to mutate (antigenic drift mechanism) due to their long-
term circulation among vaccinated populations [8]. Serology
represents a powerful and sensitive approach for detecting the
presence of avian influenza antibodies in a population but the
occurrence of antigenic drift and shift must be taken into
consideration as it can render subtype-specific serologic tests
(HI or neutralization assays) less sensitive for new or emerg-
ing strains of influenza [9]. Additionally, serologic cross-
reactivity with antigenically distinct influenza viruses can
occur as a consequence of precedent vaccination or exposure,
resulting in a more complicated interpretation of the sero-
logical findings. To address these issues, new assays are
warranted as summarized within Appendix A of the Con-
sultation Summary (May 2010) of an FAO-OIE-WHO Joint
Technical consultation on Avian Influenza at the Human-
Animal Interface (7–9 October, 2008, Verona, Italy) which
makes the recommendation to “develop and validate more
sensitive and specific tests for detecting antibodies to avian
influenza viruses in avian and nonavian species including
humans” [10]. As substitution rates are significantly higher in
influenza HA and NA genes compared with internal genes,
retroviral and lentiviral pseudotypes bearing HA and NA
envelope glycoproteins devolved from the rest of the virus are
ideal tools to monitor the effects of viral evolution on sero-
logical outcomes as previously shown [11–14]. They can be
used as sensitive, low-containment assays formeasuring anti-
body responses against HPAI and LPAI influenza strains [15]
and potentially against all different influenza subtypes [16, 17]
because, upon availability of the novel viral RNA/cDNA,
HA/NA genes can be sequenced, readily cloned or custom
synthesized, and pseudotyped lentiviral vectors prepared for
use in neutralization assays. Therefore, this assay can be con-
tinually updated to measure the efficacy of current vaccines
and therapeutics as well as serosurveillance. Also, the use of
lentiviral pseudotypes has shown additional advantage com-
pared to other serological assays since this system can poten-
tially be adapted to a “multiplex format”with beneficial reper-
cussions when large scale serological investigations need to
be undertaken. In this study, the flexibility of the influenza
pseudotype system has been exploited to develop a mul-
tiplex assay to study the neutralizing antibody responses
directed against HAs belonging to Influenza Group 1
(HPAI H5N1 clade 1 A/Vietnam/1194/2004 and HPAI clade
2.1.3.2 A/Indonesia/5/2005) and Group 2 (HPAI H7N1
A/chicken/Italy/13474/1999). By the incorporation of differ-
ent luciferase (Renilla and firefly) reporter genes into the
lentiviral genome of two separate pseudotypes, each bearing
an antigenically distinct envelope glycoprotein on its surface,
the presence of neutralising antibodies against two influenza
HAs has been evaluated within a single serum sample in a
single assay plate well. Initially, sera from chickens vaccinated
with a monovalent vaccine (H5N2) or from turkeys naturally
infected during an H7N3 influenza outbreak were tested
by pseudotype neutralization assay (pp-NT) assay using the
“monoplex” format and serological results were compared
to the standard reference HI test. Subsequently, H5 and H7
influenza pseudotypes were used for the screening of a panel
of sera collected from chickens vaccinated with a bivalent
vaccine (H5N9/H7N1) using a multiplex format where
subtype-specific antibody responses in the same serum sam-
ple directed against H5 and H7 pseudotypes were evaluated
exploiting the use of two different reporters and offering a
new assay format for in-field serosurveillance and vaccine
studies.Wehave also shown that these pseudotypes are highly
stable at basic cold-chain storage conditions of −20∘C and
+4∘C and after multiple rounds of freeze-thaw making these
assays potentially applicable for use in-field in endemic areas
as we have described recently for rabies and lyssaviruses
[18, 19].
2. Materials and Methods
2.1. Serum Samples. All avian sera were provided by the FAO,
OIE, and National Reference Laboratory for Newcastle Dis-
ease and Avian influenza (Istituto Zooprofilattico Speriment-
ale delle Venezie) and consisted of ten sera H5 positive
collected from chickens vaccinated with the inactivated
H5N2 (A/chicken/Hidalgo/28159-232/1994) vaccine (no. 1–
10), ten sera H7 positive (no. 11–20) collected from turkeys
during an Italian outbreak caused by an LPAI H7N3 virus
(A/turkey/Italy/2002), ten sera positive for both H7 and H5
collected from chickens vaccinated with an inactivated bival-
ent vaccine produced with the LPAI H7N1 (A/chicken/1067/
1999), and H5N9 (A/chicken/Italy/22A/1998) strains. Forty
negative sera were included in the study and were obtained
from chickens tested AI antibody-free by enzyme-linked
immunosorbent assay (ELISA) and agarose gel immunod-
iffusion (AGID) assay using standard protocols described
previously [20, 21]. Additionally, two hyperimmune sheep
sera, SH454 raised against NIBRG-14 (H5N1 HA) and 02/294
raised against A/chicken/Italy/13474/1999 (H7N1 HA), were
kindly provided by NIBSC.
2.2. Inhibition of Haemagglutination (HI) Test. All avian
sera employed in the study were tested by HI at FAO, OIE,
and National Reference Laboratory for Newcastle Disease
and Avian influenza, Istituto Zooprofilattico Sperimentale
delle Venezie with different reference antigens routinely
used for avian influenza surveillance in Italy, namely, H5N2
(A/turkey/Italy/1980), H7N3 (A/turkey/Italy/9289/V02),
H7N1 (A/Africa starling/England/983/1979), H5N9 (A/
chicken/Italy/22A/1998), and H7N1 (A/chicken/Italy/1067/
1999). For the HI tests, standard protocols were used as
described previously [22].
2.3. Firefly Luciferase and Renilla Luciferase H5/H7 Pseu-
dotypes. Lentiviral vector (carrying the luciferase reporter
gene, pCSFLW) pseudotyped with HA envelope glyco-
proteins derived from the HPAI H5N1 viruses (clade 1
A/Vietnam/1194/2004 and clade 2.1.3.2 A/Indonesia/5/2005)
and the HPAI H7N1 virus (A/chicken/Italy/13474/1999) were
produced as described previously [23, 24], except that the
neuraminidase activity was provided by a cognate NA plas-
mid in lieu of exogenous bacterial NA addition. In parallel,
using the same transfection protocol and the same batch
of HEK 293T/17 producer cells, HPAI H7 pseudotypes
(A/chicken/Italy/13474/1999) carrying the Renilla luciferase
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gene (pCRLFW), were generated [24]. Using the firefly
luciferase as marker for infection of HEK 293T/17 target cells,
titration of H5, and H7 influenza pseudotype was carried out
[23] in order to calculate the input virus dose required for
the proceeding pseudotype-based neutralization assays. The
titres of influenza pseudotypes were quantified by lumines-
cence expression, expressed as relative luminescence units
(RLU) measured by luminometer (GloMAX 96, Promega).
Two controls were required for the titration: a negative
control (cell only) and the Δ-envelope glycoprotein control
(No HA and NA). In addition, for stability studies pCSLZW,
expressing the lacZ gene [18], was used in conjunction with
the clade 1A/Vietnam/1194/2004HAand exogenous bacterial
NA (1 unit/mL; Sigma, UK) to produce lacZ pseudotype
viruses, and infection of HEK 293T/17 cells was detected
using the X-gal substrate as described by us previously [18].
Lentiviral pseudotypes bearing rabies CVS-11 [25] and HIV-1
[26] envelope glycoproteins were utilized for comparison.
2.4. Firefly Luciferase (Monoplex) pp-NT Assay. Serum sam-
ples (5 𝜇L) were twofold serially diluted in culture medium
(DMEM GlutaMAX supplemented with 15% FBS and 1%
Penicillin/Streptomycin) and mixed with pseudotype virus
(500,000 RLU luciferase input) at a 1 : 1 v/v ratio. After incuba-
tion at 37∘C for 1 hour, 1 × 104HEK 293T/17 cells were added
to each well of a white 96-well flat-bottomed tissue culture
plate. 48 hours later, pseudotype transduction titres obtained
at each of a range of dilution points were expressed as
RLU/mL, and an arithmetic mean was calculated. For each
serum sample, RLUswere normalized and comparedwith the
signal detected in the absence of pseudotype virus (equivalent
to 100% neutralization) and the signal of the negative control
(equivalent to 0% neutralization). The 50% inhibitory doses
(IC
50
) were determined as the reciprocal of serum dilution
resulting in a 50% reduction of a single round of infection
(reporter gene mediated signal).
2.5. Firefly and Renilla (Multiplex) pp-NT Assay. To allow
detection of neutralizing antibody responses against two dif-
ferent influenza viruses (H5 andH7) in the same well of a 96-
well flat-bottomed tissue culture plate, fixed amounts (cor-
responding to 500,000 RLUs estimated by prior pseudotype
titration) of both influenza pseudotypes (one containing the
firefly reporter gene and the other the Renilla reporter gene)
were added to each well in which twofold serially diluted
serum samples (5 𝜇L) were dispensed together with cell
culturemedium (DMEMGlutaMAX supplemented with 15%
FBS and 1% Penicillin/Streptomycin). After 48 hours, the
neutralizing antibody responses against each subtype were
detected by using the Dual-Glo reagent (Promega) which
differentiates between the two reporter genes as detailed in
themanufacturer’s instructions, so that neutralizing antibody
titre for each influenza pseudotype could be recorded for each
serum sample concurrently.
2.6. Data Analysis and Sequence Analysis. Data analyses were
undertaken using Excel and GraphPad Prism (Version 6).
Antibody titres observed for H5 (A/Vietnam/1194/2004 and
A/Indonesia/5/2005) and H7 (A/chicken/Italy/14374/1999)
influenza pseudotypes when used in the monoplex and mul-
tiplex assays were expressed as geometric mean titer (GMT).
Firstly, the IC
50
values were calculated, as described above,
and the serum dilution resulting in 50% neutralizing activity
reduction for each serum sample (tested in duplicate) was
transformed to logarithmic scale. Subsequently, the geomet-
ric mean of duplicate observations was calculated. Statistical
analyses for all the data and correlation coefficients (Pearson’s
correlation analysis) were performed using GraphPad Prism.
The radial tree and HA amino acid identity grid were
constructed with MATLAB (MathWorks).
3. Results
3.1. Construction of H5 and H7 Lentiviral Pseudotypes. We
have constructed H5N1 and H7N1 pseudotypes (with A/Viet
Nam/1194/2004 HA and NA, A/Indonesia/5/2005 HA and
NA, and A/chicken/Italy/13474/1999 HA and NA) encoding
the firefly luciferase reporter gene, and additionally, for use
in a multiplex assay, an H7N1 pseudotype (with A/chicken/
Italy/13474/1999 HA and NA) encoding a Renilla luciferase
reporter. The phylogenetic relationship between these pseu-
dotype serological antigens (and the other antigens utilized in
this study) can be visualized on a radial tree in Figure 1. Using
firefly luciferase as a marker for infection of HEK 293T/17
cells, it was shown that high titre functional pseudotypes
bearing these three different envelope glycoprotein pairs were
successfully produced (data not shown). Based on these virus
titres, it was decided to use 500,000 RLU as the input virus
dose for subsequent neutralization assays.
3.2. Stability of H5 Lentiviral Pseudotypes. The requirements
and reliability of cold-chain storage in laboratories undertak-
ing AI serology vary greatly, especially in resource limited
regions of the world. Therefore, if these pseudotype-based
assays are to be adopted in these regions in the future, it
is assumed, primarily for cost reasons, that lacZ will be the
reporter gene of choice and that these laboratories may have
frequent disruptions to ideal pseudotype storage conditions
(−80∘C) or simply may have no access to a −80∘C freezer. We
therefore undertook a series of A/Viet Nam/1194/2004 HA
pseudotype virus stability investigations by storage of this
virus at the higher temperatures of −20∘C (standard freezer),
+4∘C (standard fridge), and room temperature and by sub-
jecting the pseudotype virus to multiple freeze-thaw cycles.
The initial titre of the H5 lacZ pseudotype was 4.3 ×
105 IFU/mL and >80% infectivity remained after five cycles
of freeze-thaw (Figure 2). In parallel, pseudotypes bearing
rabies CVS-11 and HIV-1 envelope glycoproteins were sub-
jected to the same freeze-thaw regimen and were found to
lose approximately 4% and 9% activity, respectively, per
freeze-thaw cycle (Figure 2). In relation to temperature
storage variations and their effect on pseudotype viability,
Figure 3 shows that H5 A/Viet Nam/1194/2004 HA pseudo-
types stored at −20∘C maintained infectivity (of >80% com-
pared to storage at −80∘C) for at least 6months, making these
assays readily applicable in the vast majority of laboratories
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Figure 1: Radial phylogenetic tree showing the relationship between the full-length HA genes of vaccine and serological antigens (MATLAB
Software). MV: monovalent vaccine strain, BV: bivalent vaccine strain. Viruses encircled in blue represent vaccine strains, in red represent
pseudotype antigen strains, and in green represent HI antigen strains. The amino acid identity of these strains is shown in Figure 4.
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Figure 2: The influence of freeze-thaw cycles on pseudotype virus
titre. The stability of H5N1 lacZ pseudotypes was evaluated by
subjecting aliquots of virus to 5 cycles of freeze-thaw. Results for
pseudotypes bearing the rabies virus (CVS-11) and HIV-1 envelope
proteins are shown for comparison. One biological replicate of each
pseudotype virus was used to generate three technical replicates.
Error bars represent standard deviation.
worldwide. As also shown in Figure 3, these viruses could
additionally be stored at +4∘C for up to 4 weeks (with a 50%
reduction in infectivity) and at room temperature (23∘C) for
1 week (with a 50% reduction in infectivity).
3.3. Monoplex pp-NT Assay Using HPAI H5 and H7 Influenza
Pseudotypes. Three panels of sera (H5 positive, H7 positive,
and 40 negative serum samples) were initially tested using a
monoplex pseudotype-based format. An initial pilot study
was carried out where H5N1 hyperimmune (SH454) and
H7N1 (02/294) sheep sera were tested for the ability to
neutralize influenza pseudotypes bearing theHAs fromH5N1
A/Vietnam/1194/2004 andH7N1A/chicken/Italy/13474/1999.
2 10 24 48 4
0
20
40
60
80
100
120
140
RT
Hours
Incubation time
−20
+4
MonthsWeeksDays
7 2 4 2 3 64
 P
er
ce
nt
ag
e o
f i
ni
tia
l v
iru
s t
itr
e r
em
ai
ni
ng
 
Figure 3: The influence of different storage temperatures on
pseudotype virus titre. The stability of H5N1 lacZ pseudotypes was
evaluated by storing aliquots of virus at different temperatures for up
to 6 months. Pseudotype titres for the time course are given relative
to the titre of virus stocks maintained at −80∘C which is considered
the optimal storage temperature for retroviral pseudotypes. One
biological replicate pseudotype virus was used to generate three
technical replicates. Error bars represent standard deviation.
TheH5 influenza pseudotypes were neutralized by the SH454
sera (100% inhibition of pseudotype entry at 1 : 1280 serum
dilution) but not by the 02/294 sera whilst the H7 pseudo-
types were neutralized by 02/294 (with a 100% inhibition at
dilution 1 : 1280) but not by SH454. This lack of cross-
neutralizing antibody response between H5 and H7 subtypes
was consistent with the different clustering, within Group 1
andGroup 2, of HA-subtypes based on phylogenetic relation-
ship analysis of influenza subtypes. According to this analysis,
H5 HA belongs to Group 1 “cluster 1” (together with H1,
and H2, H6) and H7 HA belongs to Group 2 “cluster 7”
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Table 1: Comparison of neutralizing activity of a panel of sera collected from chickens vaccinated with an inactivated H5N2 monovalent
vaccine.
Serum number
H5 positive sera (H5N2 monovalent vaccine)
GMT titres
H5N1 A/Vietnam/1194/04
GMT titres
H5N1 A/Indonesia/5/05
GMT titres
H7N1 A/chicken/13474/99
HI titres
H5N2 A/chicken/Italy/80
1 2560 2560 28 2048
2 2560 2560 113 2048
3 640 1280 10 512
4 1810 2560 10 2048
5 453 453 10 1024
6 1280 905 28 1024
7 226 226 10 512
8 113 160 113 128
9 640 905 28 512
10 640 453 57 512
H5N1+ 1280 — — —
Negatives (40 tot.)
≤1 : 10 ≤1 : 10 — 1 : 2
GMT titres were calculated and expressed as the reciprocal of serum dilution at which a 50% inhibition of pseudotype (IC50) entry was observed.
pp pp ppMV HI HIBV BV
H5 H7
A/Vietnam/
1194/2004(H5N1)/1-568
1-568
1-568 1-568 1-564 1-564 1-564 1-564 1-532 1-560
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1-564
1-564
1-532
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Figure 4: Amino acid identity grid for pseudotype, HI, and vaccine antigen strains. MV: monovalent vaccine antigen, BV: bivalent vaccine
antigen, pp: pseudotype antigen, and HI: haemagglutination inhibition assay antigen.
(together with H10 and H15) [27]. Subsequently, a panel of
ten sera collected from chickens vaccinated with a mono-
valent inactivated vaccine produced with an H5N2 strain
(A/chicken/Hidalgo/232/1994) were run in order to more
comprehensively evaluate the utility of this assay in an avian
serological setting (tested using H5N1 A/Vietnam/1194/2004,
H5N1 A/Indonesia/5/2005, and H7N1 A/chicken/13474/1999
pseudotyped particles). Serological profiles obtained by pp-
NT assays were also compared with those obtained by HI
tests. All ten sera positive by HI test using an H5N2
A/chicken/Italy/1080 reference antigen (with titres ranging
from 1 : 128 to 1 : 2048) were also confirmed positive by pp-NT
assay usingH5N1A/Vietnam/1194/2004 (GMT range 1 : 113 to
1 : 2560) and H5N1 A/Indonesia/5/2005 (GMT range 1 : 60 to
1 : 2560) (Table 1). When this panel was tested against H7
HPAI pseudotypes, six of ten sera were also found positive
with GMT ranging from 1 : 28 to 1 : 113 (Table 1).
As shown in Figure 5(a), titres obtained via HI cor-
related strongly with titres obtained using HPAI H5 pseudo-
types belonging to two different clades: clade 1 A/Vietnam/
1194/2004 (𝑟 = 0.87, 𝑃 < 0.0001) and clade 2.1.3.2
A/Indonesia/5/2005 (𝑟 = 0.87, 𝑃 < 0.0002) despite the fact
the HAs used in the two serological assays were not optimally
matched. The percentage amino acid identities between the
pseudotype antigens, the HI antigen, and the vaccine antigen
are shown in Figure 4.
It was also observed (Figure 5(b)) that all ten sera neutral-
ized both H5 HPAI pseudotyped viruses but with a different
magnitude; it was found that the absolute titers (expressed as
mean ± SD) of H5 A/Vietnam/1194/2004 (222.96) were sig-
nificantly lower than those obtained for the same panel tested
by A/Indonesia/5/2005 (1206.2) as confirmed by 𝑃 value
<0.0001 and 𝑟 = 0.93 when analyzed using Student’s 𝑡-Test
(paired data set) (Figure 5).
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Table 2: Comparison of neutralizing activity of panel of sera collected from naturally infected turkeys with H7N3 A/turkey/Italy/2002.
Serum number
H7 positive sera (H7N3 positive, naturally infected)
GMT titres
H7N1 A/chicken/13474/99
GMT titres
H5N1 A/Vietnam/1194/04
HI titres
A/ty/Italy/9289/V02 H7N3
11 320 10 64
12 320 10 32
13 2560 10 128
14 28 10 64
15 2560 10 128
16 80 10 32
17 226 10 32
18 640 28 32
19 640 10 128
20 1280 10 64
H7N1+ 1 : 1280 ≤1 : 10 —
Negatives (40 tot.)
≤1 : 10 — 1 : 2
GMT titres were calculated and expressed as the reciprocal of the serum dilution at which 50% inhibition of pseudotype (IC50) entry was observed.
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Figure 5: (a) Comparison of pp-NT with HI titers. Scatterplots showing the correlation of antibody logarithmic titers measured by pp-NT
versus HI. For the pp-NT assay, HPAI H5 from A/Vietnam/1194/04 VN04 and A/Indonesia/5/05 (IND05) were tested. Pearson’s correlation
analysis was carried out and the coefficient of determination (𝑟2) for each strain reported on the graph. (b) Paired 𝑡-test performed by using
GraphPad.
Next, a panel of ten sera obtained from turkeys naturally
infected with an H7N3 strain with titres ranging from low
(1 : 32) to high (1 : 128) as tested by HI (HI reference antigen:
H7N3 A/turkey/Italy/9289/V02) were subsequently tested
using H7 pseudotypes A/chicken/Italy/13474/1999 and H5
A/Vietnam/1194/2004. All ten sera (no. 11 to no. 20) were
found positive when tested against H7 pseudotypes with
GMT range from 1 : 28 to 1 > 2560 while only one serum
sample was positive (GMT of 1 : 28) against H5 A/Vietnam/
1194/2004 (Table 2).
As previously shown for the panel of H5 positive sera, a
comparative serological approach was undertaken in order to
assess whether the results obtained with the pseudotype
neutralization assay reflected those obtained with HI test
using a regression analysis on paired datasets (generated from
all 51 samples comprising also the negative sera) and the Pear-
son’s correlation test. The results of this analysis revealed a
highly statistically significant correlation (𝑃 < 0.001) bet-
ween antibody titers obtained with both assays. The corre-
lation coefficient between pp-NT and HI for the panel of H7
positive was 0.72 (Figure 6).
3.4. Multiplex Assay by Using HPAI H5 and H7 Influenza
Pseudotypes Expressing Firefly and Renilla Luciferase Reporter
Gene. For a panel of sera collected from chickens vaccinated
with an inactivated bivalent vaccine (BV) produced with
the avian influenza vaccine strains H7N1 (A/chicken/Italy/
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Figure 6:Comparison of pp-NTwithHI titers. Scatterplots showing
the correlation of antibody logarithmic titers measured by pp-
NT (using HPAI H7 A/chicken/Italy/13474/99 pp) versus HI (HI
antigen: H7N3 A/ty/Italy/9289/V02). The total number of sera was
51. Graph shows the linear regression fitted to the data using
GraphPad.
1067/1999, LPAI) and H5N9 (A/chicken/Italy/22A/1998,
LPAI), monoplex (as described before) and multiplex (by
using firefly/Renilla) pp-NT assays were undertaken against
H5 A/Vietnam/1194/2004 and H7 A/chicken/Italy/13474/
1999 pseudotypes. As shown in Table 3, 9/10 sera were con-
firmed positivewhen tested by themonoplex assay againstH5
A/Vietnam/1194/2004 with titres (expressed as GMT) rang-
ing between 1 : 28 to 1 : 905; only one serum sample (n.
H5+7s3), positive by HI (1 : 64), was found negative by pp-
NT (GMT = 10). Neutralizing antibody responses against H5
A/Indonesia/5/2005were also foundpositive (10/10 sera)with
GMTs ranging between 1 : 28 and 1 : 905 and showing, as seen
for the panel of H5 positive sera (Table 1), overall higher
GMTs compared to H5N1 pseudotypes belonging to clade 1.
Also for H7N1 pseudotypes the GMTs mirrored those
obtainedwithH5N1 pseudotypes (GMTs from 1 : 40 to 1 : 453)
with one serum sample (n. H5+7s3) negative (GMT= 10) and
two sera at the proposed positive threshold of 1 : 40.
Subsequently, neutralizing antibody titres, obtainedwhen
standard and dual H5/H7 assays were undertaken (GMT
reported in Table 3), revealed a strong correlation between
the results of the standard and dual pp-NT assays (0.86; 𝑃 <
0.0001; Pearson’s correlation; Figure 7).
Neutralizing antibody titres obtained by monoplex assay
(using H5 A/Vietnam/1194/2004 carrying the firefly luci-
ferase gene) mirrored those obtained when the same panel
of sera were tested against H5 A/Vietnam/1194/2004 (firefly
gene) mixed with H7 A/chicken/13474/1999 carrying the
Renilla gene (𝑟 = 0.85, 𝑃 = 0.001). Similar results were
observed for antibody responses againstH7A/chicken/13474/
1999 tested in monoplex and multiplex assays (𝑟 = 0.91, 𝑃 =
0.0002) (Figure 7). The magnitude of neutralizing antibody
responses observed by pp-NT assays reflected those obtained
by the standard HI test although the HI test had to be per-
formed for evaluating HA-mediated antibody responses
versus both influenza antigens H5N9 (A/chicken/Italy/22A/
1998) and H7N1 (A/chicken/Italy/1067/1999) (Table 3).
4. Discussion and Conclusion
Since 1997, H5 and H7 outbreaks in domestic poultry have
been increasing in frequency and it is likely to be due to a
complex set of factors such as improved diagnostic tools,
climate fluctuations, and changes in trade flows of poultry
products [28]. One logical step to understand and limit the
possible spread of avian influenza viruses to humans and to
control the circulation amongst avian species is the monitor-
ing of AI virus exposure in poultry initially via identification
of active infections. However, due to the ability of influenza
viruses to circumvent immunity acquired through infection
or vaccination by progressive antigenic drift, serological
surveillance of avian samples is also particularly important
[29, 30]. Serological techniques play a key role in various
aspects of influenza surveillance, vaccine development, and
evaluation and they can be used to assess the presence of
antibodies to past infections and responses to a circulating
influenza strain or vaccine components [31]. From a veteri-
nary point of view, serological and virological surveillances
are necessary not only as monitoring systems for AI viruses
circulating among poultry species but also as a prevention
and control tool for those strains with possible pandemic
potential [32, 33].
Recent studies have provided the impetus that the future
of avian serology, rather than moving towards a single assay
approach, is the implementation of a strategy that involves
conventional and novel technologies to be used in conjunc-
tion with validated and standard tests. Comparative serology
aims to achieve a more holistic view of the serological
response and newer assays like the pseudotype-based neu-
tralization assay presented in this study are key [14, 23]. We
have shown previously that retroviral pseudotypes (MLV)
based onA/Viet Nam/1194/2004 can be used tomeasure anti-
body responses in chickens immunized with H5N1, H5N2,
H5N3, H5N7, and H5N9 avian viruses [11]. In this current
study, lentiviral pseudotypes have been employed to form
the basis for the development of a multiplex reporter (firefly
luciferase and Renilla luciferase) neutralization assay for H5
and H7 subtype viruses. This pseudotype system allows the
measurement of neutralizing antibody responses against two
antigenically distinct AI HA envelope glycoproteins in the
same avian serum sample. The individual components
employed for the construction of the pseudotypes used for
this multiplex assay have been chosen from a set of inter-
changeable plasmids which we have available for assay devel-
opment. These are retroviral and lentiviral plasmids coding
for the gag-pol core structural proteins, HA and NA expres-
sion plasmids, and retroviral vectors incorporating the
reporter gene. Firefly and Renilla luciferases were employed
in this study, but potentially a wide range of reporter genes
can be used in these assays (green fluorescence protein (GFP),
red (RFP)/yellow (YFP), secreted embryonic alkaline phos-
phatase (SEAP), and lac-Z) [18, 19, 34, 35]. In order for
pseudotype assays to have wide applicability and deployment
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Table 3: Evaluation of antibody responses in sera collected from chickens vaccinated with a bivalent vaccine (H5/H7) by using the monoplex
and multiplex assay formats.
Serum number HIH7N1
H7 pp-NT
monoplex
A/ck/Italy/13474/99
H7 pp-NT
multiplex
(with H5 VN04)
Serum number HIH5N9
H5 pp-NT
monoplex
VN04
H5 pp-NT
monoplex
H5 IND05
H5 pp-NT
multiplex
(with H7)
H5+7s1 32 40 40 H5+7s1 32 57 80 40
H5+7s2 16 57 80 H5+7s2 32 57 80 28
H5+7s3 32 10 10 H5+7s3 64 10 28 10
H5+7s4 16 40 40 H5+7s4 16 28 40 28
H5+7s5 32 453 320 H5+7s5 64 905 453 453
H5+7s6 32 226 226 H5+7s6 32 160 160 226
H5+7s7 16 113 113 H5+7s7 32 226 320 160
H5+7s8 16 57 57 H5+7s8 64 57 80 57
H5+7s9 16 80 113 H5+7s9 32 453 905 320
H5+7s10 32 226 320 H5+7s10 32 905 905 1280
Values are reported as geometric mean titres. Left side: values for H7 A/chicken/Italy/13474/99 tested in monoplex and multiplex are reported. Right side:
values for H5 A/Vietnam/1194/04 tested in monoplex and multiplex are reported and the panel of sera was additionally tested against A/Indonesia/5/05.
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Figure 7: (a) Correlation of monoplex versus multiplex IC
50
pseudotype neutralization titres for sera collected from chickens vaccinated
with an inactivated bivalent vaccine produced with the AI strains H7N1 (A/ck/Italy/1067/99, LPAI) and H5N9 (A/ck/Italy/22A/98, LPAI).
Antibody titres between monoplex and multiplex assays correlate when tested with both H5 and H7 pseudotypes. Neutralizing titres against
H5 A/Vietnam/1194/2004 (grey dots) and H7 A/chicken/Italy/13474/1999 (empty circles) were determined in separate wells (single) or in
the same well (multiplex). Correlation coefficient and 𝑃 values were calculated using Pearson’s correlation. Plot drawn with GraphPad.
(b) IC
50
values for each sera tested by monoplex and multiplex pp-NT assays using H5 A/Vietnam/1194/04 (firefly luciferase gene) and
H7 A/chicken/Itlay/13474/1999 (carrying firefly luciferase and Renilla luciferase gene) were calculated and plotted (the wide horizontal bar
represents the means of IC
50
titres). Results were subsequently analyzed by performing Student’s 𝑡-test on the paired dataset.
potential within different laboratories worldwide, the avail-
ability of different reporter systems is highly desirable. The
HIV-based GFP reporter plasmid (pCSGW), which we have
described previously in the context of pseudotype-based
neutralization assays [23], has been modified by PCR sub-
cloning to express alternative reporter genes.These are firefly
luciferase (pCSFLW), Renilla luciferase (pCSRLW), and lac-Z
(pCSLZW) [19, 24]. Of the three types, the luciferase reporter
based assays are the most sensitive and reproducible and also
the simplest to use in terms of hands-on time and down-
stream data analysis. This was the reason they were chosen
for the serological assays described in this current study.
However, due to the relatively high cost of the necessary
reagents (luciferase assay) andnecessity for specialized equip-
ment (luminometer), luciferase assays may have limited
applicability for laboratories in resource poor regions. GFP
based assays do not require any supplementary reagents but
donecessitate specialized equipment (fluorescentmicroscope
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or 96-well plate flow cytometry facility). The cost of a basic
fluorescent microscope however is now under $5000 making
this technology applicable for middle to low-resource lab
deployment.The lac-Z based assays are themost cost effective
as the necessary reagents are cheaply available and specialized
equipment is unnecessarymaking them ideal for deployment
in resource poor areas where serosurveillance in domestic
poultry is likely to be carried out. In addition to firefly/Renilla
(used in this study), it is technically feasible tomultiplex pairs
of pseudotype viruses carrying GFP/RFP and lacZ/SEAP
combinations for low-resource laboratory use. Lac-Z was
thus chosen as the reporter gene of choice for the “in-field”
applicability studies involving the freeze-thawing and storing
of pseudotype viruses outside of a −80∘C facility as was used
recently for similar studies with lyssavirus pseudotypes [18].
Our results showed them to be highly suitable for such use as
they were stable over time at different storage temperatures
and when subjected to multiple cycles of freeze-thaw. Inter-
estingly the pseudotype virus bearing the HIV envelope gly-
coprotein was significantly more sensitive to the freeze-thaw
procedure than the viruses bearing influenza or rabies virus
glycoproteins. This is most likely due to the fact that HIV
glycoprotein is relatively unstable when frozen. Additionally,
with the multiplex assay using the dual reporter gene system,
the interassay variability is likely to be reduced since only a
single serum dilution series needs to be performed.The same
preparation of target cells is used for two viruses and the
antibody response to the H5 subtype virus may serve as an
internal “serocontrol” for the antibody response to the H7
subtypes and vice versa as two separate luciferase reporters
were employed.
Results collected from pp-NT assays were statistically
significant when performed in monoplex andmultiplex from
both H5 (𝑃 = 0.001) and H7 (𝑃 = 0.0002) influenza strains
with results from the monoplex mirroring those obtained
with the multiplex assay (Figure 7). This system could
be subsequently refined with the possibility of increasing
the multiplexing capability (use of more reporter systems
by detecting luminescence and fluorescence signals, e.g.,
GFP/RFP with firefly/Renilla luciferase) and it could readily
be adapted to high-throughput if large serum panels are used.
There are also beneficial economic implications to the use of
this assay since the antibody responses against two viruses do
not require high-containment facilities and relatively fewer
reagents than HI and MN tests. The pp-NT assay described
here is both “serum sparing” and “antigen sparing” as only
≤5 𝜇L and, especially for certain HPAI strains, less than 10 𝜇L
(corresponding to a pseudotype input of 10e6 RLU) pseu-
dotypes per 96-well plate is required. It is possible with the
multiplex pp-NT assay to measure neutralizing antibody
responses against large panels ofH5/H7 influenza viruses and
drift variants faster and more accurately than laborious wild-
type virus microneutralization, thus providing comprehen-
sive data on antigenic evolution of avian influenza viruses.
Moreover, the major limitations to the use of HI assay are
that it is not practical for general influenza A screening with
significant level of intralaboratory variability as demonstrated
in human serology [36]. It requires a greater amount of
sera and the occurrence of cross-reactivity between subtypes
needs to be taken into account. On the contrary, pseudotype
particles have been shown to be particularly sensitive with the
potential to detect antibody responses and variations within
influenza subclades and also showing statically significant
correlation when compared to the HI test (Table 1) (Figures 5
and 6) [23]. Recent studies have raised the possibility that the
lower incorporation of HA spikes into lentiviral pseudotypes,
compared to the wild virus, makes pseudotypes more sen-
sitive by allowing the binding of antibodies to the antigenic
sites on the HA head and also on the HA stalk [37, 38].
Based on the data obtained in this study, future refinement of
this assay is warranted and it contributes towards the rec-
ommendations for the development of new assays as out-
lined in the FAO-OIE-WHO Joint Technical Consultation
document [10]. In addition, this study provides the basis for
future composite studieswhere collaborating laboratories can
be involved to determine whether the level of intra- and
interlaboratory variability in pp-NT assay is lower than that
found with HI or indeed MN enabling the pp-NT assay to
become accepted for large scale testing, not only in the con-
text of avian and human influenza surveillance but also for
integrated surveillance of other “neglected” influenza strains
(circulating in horses, pigs, seals, and dogs for e.g.) [39].
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